Brii Biosciences Limited Market Cap ($86.84 Million)
Market Cap & Net Worth: Brii Biosciences Limited (7SS)
Brii Biosciences Limited market cap. Brii Biosciences Limited (F:7SS) has a market capitalization of $86.84 Million (€74.28 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #19559 globally and #1796 in its home market, demonstrating a 12.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brii Biosciences Limited's stock price €0.10 by its total outstanding shares 721177062 (721.18 Million). Also see how efficiently does Brii Biosciences Limited generate cash for how efficiently the company converts equity into cash flow.
Brii Biosciences Limited Market Cap History (2021–2026)
Brii Biosciences Limited market cap history from 2021 to 2026. Data shows change from $2.98 Billion to $86.84 Million (-43.51% CAGR). Check 7SS live share price for real-time trading data and today's change.
Brii Biosciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brii Biosciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 7SS net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.39x
Brii Biosciences Limited's market cap is 6.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $712.45 Million | $51.63 Million | -$484.31 Million | 13.80x | N/A |
| 2023 | $202.35 Million | $617.00K | -$174.83 Million | 327.96x | N/A |
| 2025 | $118.88 Million | $18.61 Million | -$222.62 Million | 6.39x | N/A |
Competitor Companies of 7SS by Market Capitalization
Companies near Brii Biosciences Limited in the global market cap rankings as of November 4, 2026. Also see Brii Biosciences Limited assets under control for a full breakdown of the balance sheet.
Key companies related to Brii Biosciences Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Brii Biosciences Limited (2021–2026)
Market capitalization of Brii Biosciences Limited from 2021 to today. Between 2021 and today, Brii Biosciences Limited's market cap moved from $2.98 Billion to $ 86.84 Million, with a yearly change of -43.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €86.84 Million | -26.95% |
| 2025 | €118.88 Million | +18.49% |
| 2024 | €100.33 Million | -50.42% |
| 2023 | €202.35 Million | -71.60% |
| 2022 | €712.45 Million | -76.13% |
| 2021 | €2.98 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Brii Biosciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.84 Million USD |
| MoneyControl | $86.84 Million USD |
| MarketWatch | $86.84 Million USD |
| marketcap.company | $86.84 Million USD |
| Reuters | $86.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brii Biosciences Limited
Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neut… Read more